Day One Biopharmaceuticals Financial Overview
Day One Biopharmaceuticals's market cap is currently $948.72M. The company's EPS TTM is $-0.19; its P/E ratio is -6.22; Day One Biopharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
